Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations

Modern Pathology, Published online: 28 July 2022; doi:10.1038/s41379-022-01083-xDeriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations

Source: Modern Pathology - July 28, 2022 Category: Pathology Authors: Stephanie E. Siegmund Danielle K. Manning Phani K. Davineni Fei Dong Source Type: research